• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Albemarle Corporation filed SEC Form 8-K: Leadership Update

    12/12/25 4:16:15 PM ET
    $ALB
    Major Chemicals
    Industrials
    Get the next $ALB alert in real time by email
    alb-20251208
    false000091591300009159132025-12-082025-12-080000915913us-gaap:CommonStockMember2025-12-082025-12-080000915913us-gaap:SeriesAPreferredStockMember2025-12-082025-12-08

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    _________________________________
    FORM 8-K
    _________________________________

    CURRENT REPORT
    Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

    Date of Report (Date of earliest event reported): December 8, 2025

    _________________________________
    ALBEMARLE CORPORATION
    (Exact name of registrant as specified in charter)
    _________________________________
    Virginia001-1265854-1692118
    (State or other jurisdiction
    of incorporation)
    (Commission
    File Number)
    (IRS Employer
    Identification No.)
    4250 Congress Street, Suite 900
    Charlotte, North Carolina 28209
    (Address of principal executive offices) (Zip Code)
    Registrant’s telephone number, including area code: (980) 299-5700
    Not applicable
    (Former name or former address, if changed since last report.)
    _________________________________

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
    ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐ Soliciting material pursuant to Rule 14a- 12 under the Exchange Act (17 CFR 240.14a-12)
    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:
    Title of each classTrading SymbolName of each exchange on which registered
    COMMON STOCK, $.01 Par ValueALBNew York Stock Exchange
    DEPOSITARY SHARES, each representing a 1/20th interest in a share of 7.25% Series A Mandatory Convertible Preferred StockALB PR ANew York Stock Exchange
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2).
    Emerging growth company☐
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐




    Item 5.02    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

    (b) On December 8, 2025, Dean L. Seavers tendered his resignation from the Board of Directors of Albemarle Corporation and all committees on which he serves, effective December 12, 2025. His resignation is not related to any disagreement regarding the organization’s operations, policies, or practices..





    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

    ALBEMARLE CORPORATION
    Date: December 12, 2025By:/s/ Ander C. Krupa
    Ander C. Krupa
    General Counsel and Corporate Secretary


    Get the next $ALB alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALB

    DatePrice TargetRatingAnalyst
    12/5/2025$185.00Neutral → Buy
    UBS
    12/2/2025$113.00Underperform → Neutral
    Robert W. Baird
    10/24/2025$135.00Buy
    Rothschild & Co Redburn
    10/20/2025$72.00 → $87.00Hold
    Truist
    10/14/2025$100.00Buy → Neutral
    BofA Securities
    8/26/2025$89.00Sell → Neutral
    UBS
    7/30/2025Overweight → Sector Weight
    KeyBanc Capital Markets
    7/29/2025$60.00Neutral → Underperform
    Robert W. Baird
    More analyst ratings

    $ALB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Sheorey Neal Ravi covered exercise/tax liability with 854 shares and converted options into 1,953 shares, increasing direct ownership by 10% to 12,210 units (SEC Form 4)

    4 - ALBEMARLE CORP (0000915913) (Issuer)

    11/10/25 4:13:38 PM ET
    $ALB
    Major Chemicals
    Industrials

    General Counsel & Sec Krupa Ander C. sold $18,060 worth of shares (172 units at $105.00), decreasing direct ownership by 1% to 11,483 units (SEC Form 4)

    4 - ALBEMARLE CORP (0000915913) (Issuer)

    10/28/25 4:17:35 PM ET
    $ALB
    Major Chemicals
    Industrials

    General Counsel & Sec Krupa Ander C. sold $11,020 worth of shares (116 units at $95.00), decreasing direct ownership by 0.99% to 11,655 units (SEC Form 4)

    4 - ALBEMARLE CORP (0000915913) (Issuer)

    10/14/25 4:21:28 PM ET
    $ALB
    Major Chemicals
    Industrials

    $ALB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Albemarle upgraded by UBS with a new price target

    UBS upgraded Albemarle from Neutral to Buy and set a new price target of $185.00

    12/5/25 8:30:03 AM ET
    $ALB
    Major Chemicals
    Industrials

    Albemarle upgraded by Robert W. Baird with a new price target

    Robert W. Baird upgraded Albemarle from Underperform to Neutral and set a new price target of $113.00

    12/2/25 8:16:48 AM ET
    $ALB
    Major Chemicals
    Industrials

    Rothschild & Co Redburn initiated coverage on Albemarle with a new price target

    Rothschild & Co Redburn initiated coverage of Albemarle with a rating of Buy and set a new price target of $135.00

    10/24/25 8:59:31 AM ET
    $ALB
    Major Chemicals
    Industrials

    $ALB
    SEC Filings

    View All

    $ALB
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    $ALB
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Albemarle Corporation filed SEC Form 8-K: Leadership Update

    8-K - ALBEMARLE CORP (0000915913) (Filer)

    12/12/25 4:16:15 PM ET
    $ALB
    Major Chemicals
    Industrials

    SEC Form SCHEDULE 13G filed by Albemarle Corporation

    SCHEDULE 13G - ALBEMARLE CORP (0000915913) (Subject)

    11/10/25 8:13:33 AM ET
    $ALB
    Major Chemicals
    Industrials

    SEC Form 10-Q filed by Albemarle Corporation

    10-Q - ALBEMARLE CORP (0000915913) (Filer)

    11/5/25 4:31:57 PM ET
    $ALB
    Major Chemicals
    Industrials

    Coleman Kristin M. bought $167,314 worth of shares (1,373 units at $121.86) (SEC Form 4)

    4 - ALBEMARLE CORP (0000915913) (Issuer)

    11/7/23 4:39:49 PM ET
    $ALB
    Major Chemicals
    Industrials

    Lithium Royalty Corp. Congratulates Power Metals on Offtake Agreement with Albemarle; Power Metals Reaffirms 2026 Production Target

    Power Metals entered into a cesium concentrate offtake agreement with Albemarle Corporation, a US$16 billion global critical minerals producer Albemarle has committed to a prepayment agreement of up to C$5 million, supporting advancement toward Power Metals' stated 2026 production target The Case Lake project hosts a maiden inferred cesium mineral resource of 13,000 tonnes at 2.4% Cs₂O, with additional exploration upside LRC holds a 2.0% gross overriding royalty on the Case Lake project, providing exposure to potential near-term cesium production   Lithium Royalty Corp. (TSX:LIRC) ("LRC") congratulates Power Metals Corp. ("Power Metals") on the cesium concentrate offtake agreem

    12/12/25 3:18:00 PM ET
    $ALB
    Major Chemicals
    Industrials

    Albemarle Reports Third Quarter 2025 Results

    CHARLOTTE, N.C., Nov. 5, 2025 /PRNewswire/ -- Albemarle Corporation (NYSE:ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced its results for the third quarter ended September 30, 2025. Third Quarter 2025 and Recent Highlights(Unless otherwise stated, all percentage changes represent year-over-year comparisons) Net sales of $1.3 billion, including volume growth in Energy Storage (+8%) and Ketjen (+8%).Net loss of ($161) million, or ($1.72) per diluted share attributable to common shareholders; Adjusted loss of ($

    11/5/25 4:15:00 PM ET
    $ALB
    Major Chemicals
    Industrials

    Albemarle Announces Quarterly Common Stock Dividend

    CHARLOTTE, N.C., Oct. 27, 2025 /PRNewswire/ -- The Board of Directors of Albemarle Corp. (NYSE:ALB) announced today that it declared a quarterly common stock dividend of $0.405 per share. The dividend, which has an annualized rate of $1.62, is payable January 2, 2026, to shareholders of record at the close of business as of December 12, 2025. About AlbemarleAlbemarle Corporation (NYSE:ALB) leads the world in transforming essential resources into critical ingredients for mobility, energy, connectivity and health. We partner to pioneer new ways to move, power, connect and protec

    10/27/25 4:15:00 PM ET
    $ALB
    Major Chemicals
    Industrials

    $ALB
    Leadership Updates

    Live Leadership Updates

    View All

    Ketjen Announces the Appointment of Henri Tausch as Chief Commercial Officer

    Ketjen Corporation, a leader in catalyst and specialty chemicals manufacturing, today announces the appointment of Henri Tausch to Chief Commercial Officer (CCO) effective June 24, 2024. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240619765799/en/Henri Tausch, Ketjen Chief Commercial Officer (Photo: Business Wire) In his role as Chief Commercial Officer, Tausch will oversee and advance the company's commercial strategy, and foster key partnerships to accelerate the company's global growth trajectory. "I am honored to join Ketjen and contribute to its continued success," said Henri Tausch "It's inspiring to see Ketjen's dedi

    6/19/24 7:00:00 AM ET
    $ALB
    Major Chemicals
    Industrials

    International Paper Announces Changes to Its Board of Directors

     Jamie A. Beggs and Scott A. Tozier to Join as Newest Board Members Ilene S. Gordon to Retire from the Board MEMPHIS, Tenn., May 22, 2024 /PRNewswire/ -- International Paper ("IP") (NYSE:IP) announced that Jamie A. Beggs and Scott A. Tozier have been elected to IP's Board of Directors, effective May 21, 2024. The company also announced that Ilene S. Gordon has retired from the Board citing personal and health reasons, effective May 21, 2024. Ms. Beggs, age 47, currently serves as Senior Vice President and Chief Financial Officer of Avient Corporation (NYSE:AVNT), a premier pr

    5/23/24 10:51:00 AM ET
    $ALB
    $AVNT
    $IP
    Major Chemicals
    Industrials
    Paper
    Basic Materials

    Albemarle Reports Net Sales Increase of 60% for Second Quarter 2023

    CHARLOTTE, N.C., Aug. 2, 2023 /PRNewswire/ -- Albemarle Corporation (NYSE:ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced its results for the second quarter ended June 30, 2023. Second-Quarter 2023 and Recent Highlights(Unless otherwise stated, all percentage changes represent year-over-year comparisons) Net sales of $2.4 billion, an increase of 60%Net income of $650.0 million, or $5.52 per diluted share, an increase of 60%Adjusted diluted EPS of $7.33, an increase of 112%Adjusted EBITDA of $1.0 billion, an i

    8/2/23 4:15:00 PM ET
    $ALB
    Major Chemicals
    Industrials

    $ALB
    Financials

    Live finance-specific insights

    View All

    Albemarle Reports Third Quarter 2025 Results

    CHARLOTTE, N.C., Nov. 5, 2025 /PRNewswire/ -- Albemarle Corporation (NYSE:ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced its results for the third quarter ended September 30, 2025. Third Quarter 2025 and Recent Highlights(Unless otherwise stated, all percentage changes represent year-over-year comparisons) Net sales of $1.3 billion, including volume growth in Energy Storage (+8%) and Ketjen (+8%).Net loss of ($161) million, or ($1.72) per diluted share attributable to common shareholders; Adjusted loss of ($

    11/5/25 4:15:00 PM ET
    $ALB
    Major Chemicals
    Industrials

    Albemarle Announces Quarterly Common Stock Dividend

    CHARLOTTE, N.C., Oct. 27, 2025 /PRNewswire/ -- The Board of Directors of Albemarle Corp. (NYSE:ALB) announced today that it declared a quarterly common stock dividend of $0.405 per share. The dividend, which has an annualized rate of $1.62, is payable January 2, 2026, to shareholders of record at the close of business as of December 12, 2025. About AlbemarleAlbemarle Corporation (NYSE:ALB) leads the world in transforming essential resources into critical ingredients for mobility, energy, connectivity and health. We partner to pioneer new ways to move, power, connect and protec

    10/27/25 4:15:00 PM ET
    $ALB
    Major Chemicals
    Industrials

    Albemarle Corporation to Release Third Quarter 2025 Earnings Results on Wednesday, November 5, 2025

    CHARLOTTE, N.C., Sept. 25, 2025 /PRNewswire/ -- Albemarle Corporation (NYSE: ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, announced today that it will release its third quarter 2025 earnings after the NYSE closes on Wednesday, November 5, 2025. The company will hold a conference call to discuss its third quarter 2025 results on Thursday, November 6, at 8 a.m. EST. Access to the call is available via webcast or direct dial. A link to the webcast can be found through Albemarle Corporation's website at http://investors.albem

    9/25/25 4:15:00 PM ET
    $ALB
    Major Chemicals
    Industrials

    $ALB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Albemarle Corporation

    SC 13G/A - ALBEMARLE CORP (0000915913) (Subject)

    12/5/24 7:27:01 PM ET
    $ALB
    Major Chemicals
    Industrials

    SEC Form SC 13G filed by Albemarle Corporation

    SC 13G - ALBEMARLE CORP (0000915913) (Subject)

    11/13/24 12:52:42 PM ET
    $ALB
    Major Chemicals
    Industrials

    Amendment: SEC Form SC 13G/A filed by Albemarle Corporation

    SC 13G/A - ALBEMARLE CORP (0000915913) (Subject)

    11/13/24 10:27:59 AM ET
    $ALB
    Major Chemicals
    Industrials